Location History:
- Cheshire, GB (2012)
- Macclesfield, GB (2010 - 2019)
Company Filing History:
Years Active: 2010-2019
Title: The Innovative Contributions of David Buttar
Introduction
David Buttar is a prominent inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for medical use. With a total of eight patents to his name, Buttar's work has the potential to impact cancer treatment and other cell proliferative disorders.
Latest Patents
Among his latest patents, Buttar has developed a compound of formula (I) and its pharmaceutically acceptable salts. This invention includes processes for the manufacture of the compound and its application as a medicament in cancer treatment. Additionally, he has focused on chemical compounds of formula (I) or their pharmaceutically acceptable salts, detailing their preparation processes, pharmaceutical compositions, and uses in treating cell proliferative disorders.
Career Highlights
David Buttar is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative approach and dedication to improving medical treatments have established him as a key figure in his field.
Collaborations
Buttar has collaborated with notable colleagues, including Kevin Michael Foote and Maria-Elena Theoclitou. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
David Buttar's contributions to pharmaceutical innovations are noteworthy, particularly in the realm of cancer treatment. His patents and collaborative efforts reflect a commitment to advancing medical science and improving patient outcomes.